MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.78
-0.47 (-3.84%)
At close: Jan 30, 2026, 4:00 PM EST
11.85
+0.07 (0.59%)
After-hours: Jan 30, 2026, 6:19 PM EST

MiNK Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
55283788149-
Market Cap Growth
60.40%-25.23%-58.11%-40.99%--
Enterprise Value
47263164214-
Last Close Price
11.786.9710.7026.1044.60-
PB Ratio
--1.41-2.05-219.746.29-
P/TBV Ratio
----6.29-
Debt / Equity Ratio
-0.42-0.25----0.81
Quick Ratio
1.060.660.301.552.360.21
Current Ratio
1.080.720.321.612.410.29
Return on Equity (ROE)
----239.50%--
Return on Assets (ROA)
-69.61%-137.35%-110.10%-62.69%-51.92%-230.14%
Return on Capital Employed (ROCE)
-813.00%911.20%334.60%-352.20%-78.30%111.70%
Earnings Yield
-22.34%-39.05%-60.80%-31.74%-20.22%-
FCF Yield
-10.09%-34.60%-42.87%-21.68%-8.75%-
Buyback Yield / Dilution
-12.09%-9.82%-2.04%-29.38%-7.95%-0.21%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q